Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their volatility can be an asset.

| More on:
A cannabis plant grows.

Source: Getty Images

Few bear markets in Canada have been as brutal as the one that the marijuana sector suffered through. From the giants of the industry to smaller players, almost all marijuana stocks experienced massive growth when the sentiment about the industry was highly positive, and legal marijuana was expected to be the next best thing.

But when it became clear that marijuana companies in Canada would have a long and arduous war with the black market products that still permeate a significant segment of the Canadian market, the sentiment began to change. It triggered a long and considerable slump, which caused many marijuana companies to lose up to 90% of their valuation over time.

However, hitting rock bottom has its perks. Many marijuana stocks experience a spike in performance even when something moderately good happens in the industry, and that’s what is happening with Canopy Growth (TSX:WEED) right now.

A fallen giant

Canopy Growth was one of the largest cannabis companies in the world at one time, and even though it’s still in the top 10 cannabis companies by market cap, it has fallen several steps. Several reasons exist, including a weak sector, government regulations, and the company’s own management and business model weaknesses.

One of the most significant internal weaknesses of the company is that, in the past, it has liberally used share dilution to raise the required cash. While this allowed the company to build its portfolio of products and facilities, that’s quite impressive, the long-term implications haven’t been in the company’s favour yet.

The stock has lost over 98.5% of its market valuation from its 2019 peak, when it traded upwards of $670 per share. Now, it’s barely hitting the double digits now. It was at low single digits a while back, but the news that the U.S. might decriminalize marijuana at a federal level triggered a strong bullish phase. The stock rose by about 200% in just two weeks but is already heading toward a correction phase.

The future

There is no doubt that the U.S. is heading toward federal decriminalization of marijuana. Two-dozen states have already legalized its recreational use, and commercial distribution is also permitted in most of these states. Still, the actual trigger, especially for producers in Canada (especially if they have a U.S. presence), would be the federal legalization of marijuana.

When that happens, buying Canopy Growth might result in significant short-term gains, but buying now may not be the best course of action. The stock may dip, and if you wait for the right time to buy, you can get an even more discounted price and capture a larger piece of growth than you would if you buy now.

Foolish takeaway

It’s important to note that most cannabis stocks in Canada might surge when the U.S. government legalizes cannabis, but for almost all of them, the growth will have two phases.

The initial sentiment-driven phase would push nearly all stocks up — some more; some less. Then, after a correction, there might be a second phase of growth for companies that have actually benefited from this legalization, as evidenced by their financials.  

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Adam Othman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

More on Cannabis Stocks

Cannabis grows at a commercial farm.
Cannabis Stocks

Canopy Growth Stock Is on a Tear: Is it a Good Buy Now? 

Canopy Growth (TSX:WEED) stock surged by 80% from news out of the U.S., but is enough there without the news…

Read more »

Marijuana plant and cannabis oil bottles isolated
Cannabis Stocks

Prediction: These Could Be the Best-Performing Cannabis Stocks Through 2030

Quality cannabis stocks such as Green Thumb and Cresco Labs are positioned to deliver outsized gains to shareholders in 2024…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

The Big Mistake I See Cannabis Investors Making Over and Over Again

The news of marijuana slated to be legalized next year has seen a boost for cannabis investors, but they must…

Read more »

cup of cappuccino with a sad face
Cannabis Stocks

A TSX Stock I’d Avoid at All Costs

Despite posting a massive surge in share prices, Canopy Growth (TSX:WEED) is a stock you might be better off steering…

Read more »

edit Jars of marijuana
Cannabis Stocks

4 Reasons Canopy Growth Stock Looks Like a Screaming Buy

Canopy Growth (TSX:WEED) stock has a lot going for it lately, but there are still more hurdles ahead. Even so,…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

1 Cannabis Stock to Buy Hand Over Fist and 1 to Avoid

For investors looking for a cannabis stock to buy and one to sell, here are my top two picks in…

Read more »

Marijuana plant and cannabis oil bottles isolated
Stocks for Beginners

What’s Going on With Canadian Pot Stocks?

Canadian cannabis stocks exposed to the U.S. saw a boost in share price this week from rumours that rescheduling of…

Read more »

A cannabis plant grows.
Cannabis Stocks

Tilray Just Soared 40% This Week: Is the Stock a Good Buy Now?

Tilray stock soared almost 40% in a single trading session this week after the U.S. DEA disclosed plans to reschedule…

Read more »